Identification of the Dynamic Expression Patterns of Immune Genes in the Peripheral Blood of Acute Ischemic Stroke Patients.

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Biochemical Genetics

• Publication date

  2025-11-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10528-025-11275-0PMID 41214317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Role of S100b Protein Biomarker in Brain Death: A Literature Review

  2024cited by this paper
• Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models

  2023cited by this paper
• Role of Inflammatory Processes in Hemorrhagic Stroke.

  2023cited by this paper
• Is Immune Suppression Involved in the Ischemic Stroke? A Study Based on Computational Biology

  2022cited by this paper
• Sevoflurane postconditioning ameliorates cerebral ischemia-reperfusion injury in rats via TLR4/MyD88/TRAF6 signaling pathway

  2022cited by this paper
• Loss‐of‐Function of p21‐Activated Kinase 2 Links BMP Signaling to Neural Tube Patterning Defects

  2022cited by this paper
• Guhong Injection Prevents Ischemic Stroke-Induced Neuro-Inflammation and Neuron Loss Through Regulation of C5ar1

  2022cited by this paper
• Systemic Immune-Inflammation Index Predicts 3-Month Functional Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis

  2021cited by this paper
• Machine Learning in Action: Stroke Diagnosis and Outcome Prediction

  2021cited by this paper
• Role of TLR4 in Neutrophil Dynamics and Functions: Contribution to Stroke Pathophysiology

  2021cited by this paper
• Acute Inflammation in Cerebrovascular Disease: A Critical Reappraisal with Focus on Human Studies

  2021cited by this paper
• C5aR1 Mediates the Progression of Inflammatory Responses in the Brain of Rats in the Early Stage after Ischemia and Reperfusion.

  2021cited by this paper
• FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC

  2021cited by this paper
• IGF2R circular RNA hsa_circ_0131235 expression in the middle temporal cortex is associated with AD pathology

  2021cited by this paper
• FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin

  2020cited by this paper
• Effects of Liposome and Cardiolipin on Folding and Function of Mitochondrial Erv1

  2020cited by this paper
• Novel Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  2020cited by this paper
• Filling the gaps on stroke research: Focus on inflammation and immunity

  2020cited by this paper
• New predictors for immunotherapy responses sharpen our view of the tumour microenvironment

  2020cited by this paper
• Endothelial progenitor cells: Potential novel therapeutics for ischaemic stroke.

  2019cited by this paper
• Global brain inflammation in stroke.

  2019cited by this paper
• The complement system in schizophrenia: where are we now and what’s next?

  2019cited by this paper
• RBM3 promotes neurogenesis in a niche-dependent manner via IMP2-IGF2 signaling pathway after hypoxic-ischemic brain injury

  2019cited by this paper
• A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments

  2018cited by this paper
• Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16‐mediated Effects

  2018cited by this paper
• Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer

  2017cited by this paper
• Vinpocetine alleviate cerebral ischemia/reperfusion injury by down-regulating TLR4/MyD88/NF-κB signaling

  2017cited by this paper
• Metabolic Stress-Induced Phosphorylation of KAP1 Ser473 Blocks Mitochondrial Fusion in Breast Cancer Cells.

  2016cited by this paper
• Monoclonal antibodies targeting CD38 in hematological malignancies and beyond

  2016cited by this paper
• Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy

  2015cited by this paper
• Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes

  2015cited by this paper
• NKp30 isoforms in patients with chronic hepatitis C virus infection

  2015cited by this paper
• Genes and pathways underlying regional and cell type changes in Alzheimer's disease

  2013cited by this paper
• FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis

  2013cited by this paper
• Complement in Immune and Inflammatory Disorders: Pathophysiological Mechanisms

  2013cited by this paper
• The immunology of acute stroke

  2012cited by this paper
• Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6

  2011cited by this paper
• Stroke and the immune system: from pathophysiology to new therapeutic strategies.

  2011cited by this paper
• Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.

  2009cited by this paper
• Complement component 5a (C5a).

  2009cited by this paper
• Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits

  2007cited by this paper
• Recent developments in C5/C5a inhibitors

  2006cited by this paper
• Toll-Like Receptor 2 Signaling in Response to Brain Injury: An Innate Bridge to Neuroinflammation

  2006cited by this paper
• Role of C5a in inflammatory responses.

  2005cited by this paper
• Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

  2001cited by this paper
• Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor gamma-chain signaling and inhibited by cyclosporin A.

  2001cited by this paper
• Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

  1999cited by this paper

• No citing papers are available for this paper.